Literature DB >> 12741766

Long-term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres.

Giuseppe De Rosa1, Fabiana Quaglia, Amélie Bochot, Francesca Ungaro, Elias Fattal.   

Abstract

The aim of this work was to design a biodegradable delivery system for oligonucleotides providing both a sustained release and an improved intracellular penetration. To this purpose oligonucleotide/polyethylenimine (ON/PEI) complexes at nitrogen to phosphate (N/P) molar ratios of about 15 or 40 were encapsulated into poly(lactide-co-glycolide) microspheres by the multiple emulsion-solvent evaporation technique. ON/PEI complexes were efficiently entrapped inside microspheres. The introduction of salts within the external aqueous phase allowed an improvement of microsphere characteristics. In particular, the use of sodium chloride led to a reduced microsphere porosity and a more homogeneous ON distribution inside the polymeric matrix. These effects were attributed to the reduced flux of water from the external aqueous phase toward the internal aqueous droplets, due to the osmotic effect of sodium chloride. Both, the reduced porosity and the improved ON distribution inside the matrix, were considered responsible for the lower burst effect and the slower ON release rate from microsphere prepared with sodium chloride. ON/PEI complexes encapsulated inside microspheres were also protected toward enzymatic degradation in fetal calf serum. Interestingly, ON/PEI complexes slowly released from microspheres efficiently penetrated inside HeLa cells and oligonucleotides were preferentially located in the nucleus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12741766     DOI: 10.1021/bm025684c

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  8 in total

Review 1.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

2.  Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.

Authors:  Ying Zhang; Andreas M Sophocleous; Steven P Schwendeman
Journal:  Pharm Res       Date:  2009-06-16       Impact factor: 4.200

3.  NF-κB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells.

Authors:  N H Abd Ellah; L Taylor; N Ayres; M M Elmahdy; G N Fetih; H N Jones; E A Ibrahim; G M Pauletti
Journal:  Cancer Gene Ther       Date:  2016-04-29       Impact factor: 5.987

4.  Enhancement of poly(orthoester) microspheres for DNA vaccine delivery by blending with poly(ethylenimine).

Authors:  David N Nguyen; Shyam S Raghavan; Lauren M Tashima; Elizabeth C Lin; Stephen J Fredette; Robert S Langer; Chun Wang
Journal:  Biomaterials       Date:  2008-04-09       Impact factor: 12.479

Review 5.  Recent perspectives in ocular drug delivery.

Authors:  Ripal Gaudana; J Jwala; Sai H S Boddu; Ashim K Mitra
Journal:  Pharm Res       Date:  2008-08-29       Impact factor: 4.200

6.  PEI-engineered respirable particles delivering a decoy oligonucleotide to NF-κB: inhibiting MUC2 expression in LPS-stimulated airway epithelial cells.

Authors:  Francesca Ungaro; Daniela De Stefano; Concetta Giovino; Alessia Masuccio; Agnese Miro; Raffaella Sorrentino; Rosa Carnuccio; Fabiana Quaglia
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

7.  Poly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epithelium.

Authors:  Denise S Conti; Daniel Brewer; Jordan Grashik; Sumant Avasarala; Sandro R P da Rocha
Journal:  Mol Pharm       Date:  2014-05-08       Impact factor: 4.939

Review 8.  Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties.

Authors:  Giuseppe De Rosa; Maria Immacolata La Rotonda
Journal:  Molecules       Date:  2009-07-29       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.